Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2024-04-21 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
关于对会计师事务所 2023 年度履职情况评估的报告
Audit Report / Information Classification · 95% confidence The document is a detailed report evaluating the performance of the accounting firm (auditor) for the year 2023. It discusses the auditor's qualifications, audit procedures, quality control, and overall assessment of the auditor's work related to the company's 2023 annual audit. The content focuses on the audit firm's role and performance rather than presenting the company's financial statements or full audit report itself. This matches the description of an Audit Report / Information (AR), which includes standalone audit reports and evaluations of accounting firms' performance. The document is not an Annual Report (10-K) or an Interim Report (IR) because it does not contain the company's financial statements or comprehensive financial data. It is also not a Regulatory Filing (RNS) or Report Publication Announcement (RPA) because it contains substantive evaluation content rather than just an announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2023
2024-04-21 Chinese
独立董事2023年度述职报告（刘霄仑）
Board/Management Information Classification · 95% confidence The document is a detailed annual report by an independent director of a company, covering the director's duties, attendance, opinions on various company matters, committee work, communication with auditors, and other governance-related activities during the year 2023. It includes detailed descriptions of board meetings, independent opinions on financial and operational matters, and governance issues. The document is lengthy (9454 characters) and contains substantive content about management and board activities rather than just an announcement or summary. It is not a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a simple announcement or certification. The content focuses on the independent director's management and governance role, which aligns with the category Board/Management Information (MANG).
2024-04-21 Chinese
独立董事2023年度述职报告（陈晓满）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2023 Annual Work Report" for Yingkang Life Technology Co., Ltd. It details the independent director's activities, attendance at board and shareholder meetings, opinions on company matters, communication with audit institutions, and other governance-related duties during the 2023 fiscal year. The content focuses on the independent director's role, responsibilities, and evaluations rather than financial statements or audit results. It is a detailed report on board/management information, specifically the independent director's annual report on their duties and observations. It is not an annual report (10-K), audit report (AR), or any other financial or regulatory filing. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length (7743 characters) supports it being a full report rather than a brief announcement or certification.
2024-04-21 Chinese
2023年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2023 Annual Report Summary" of 盈康生命科技股份有限公司, indicating it is a summary of the company's annual report. It contains detailed financial data for the year 2023, including revenue, net profit, and other financial indicators. It also includes comprehensive business descriptions, operational highlights, and strategic information typical of an annual report. The document is lengthy (15,000 characters) and contains substantive financial and operational data, not just an announcement or a certification. Therefore, it fits the definition of an Annual Report (10-K). FY 2023
2024-04-21 Chinese
关于2023年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a special report on the storage and use of raised funds for the year 2023 by 盈康生命科技股份有限公司. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange regarding the management and use of raised funds. The content details the amount of funds raised, usage during the reporting period, storage, management, and compliance with regulatory requirements. It is a focused report on fundraising capital usage rather than a general financial report or announcement. The document length is about 4611 characters, which is sufficient for a detailed report rather than a brief announcement. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. Therefore, the appropriate classification is CAP with high confidence.
2024-04-21 Chinese
关于举行2023年度报告网上业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about holding an online performance explanation meeting (业绩说明会) related to the 2023 annual report. It mentions that the 2023 annual report and its summary have already been disclosed on April 22, 2024, and invites investors to participate in the online meeting on April 29, 2024. The document is short (866 characters) and serves as a notice for the upcoming investor presentation rather than containing the report itself or detailed financial data. According to the 'Menu vs Meal' rule, this is an announcement about a report-related event, not the report itself. Therefore, the document fits best into the category of Investor Presentation (IP).
2024-04-21 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.